Clinical Trial Update: Xenon Inhalation for Treatment of Panic Disorder [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for xenon inhalation targeting panic disorder in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• Xenon inhalation (xenon)

Snippet

Sponsor: Nobilis Therapeutics Inc. | Conditions: Panic Disorder | Phase 2, Phase 3 | Status: UNKNOWN